Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.

about

Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.

Item

http://www.wikidata.org/entity/Q39748512

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@en

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@nl

type

Item

label

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@en

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@nl

prefLabel

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@en

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@nl

P1476

Antidepressant-like Effects of ...... pinephrine Reuptake Inhibitor.

@en

P2093

Bo-Hua Zhong

http://www.w3.org/2001/XMLSchema#string

Jin Li

http://www.w3.org/2001/XMLSchema#string

Qiong-Yin Fan

http://www.w3.org/2001/XMLSchema#string

Rui Xue

http://www.w3.org/2001/XMLSchema#string

Shi-Yong Fan

http://www.w3.org/2001/XMLSchema#string

Ting-Ting Zhang

http://www.w3.org/2001/XMLSchema#string

Ying Li

http://www.w3.org/2001/XMLSchema#string

You-Zhi Zhang

http://www.w3.org/2001/XMLSchema#string

Yun-Feng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Dance movement therapy for depression

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Cross-national epidemiology of DSM-IV major depressive episode.

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.

Can recovery from depression be achieved?

Pharmacological principles of antidepressant efficacy.

P304

700-706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CNS.12567

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xinhua He

P577

2016-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27207183

http://www.w3.org/2001/XMLSchema#string

P921

serotonin

norepinephrine

P932

6492862

http://www.w3.org/2001/XMLSchema#string